Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
Rosa Bacchetta(The San Raffaele Telethon Institute for Gene Therapy), Maria‐Grazia Roncarolo(Regenerative Medicine Institute), Stefan Tomiuk(European Union), Uwe Janßen(European Union), Raffaella Greco(Vita-Salute San Raffaele University), Fabio Ciceri(San Antonio College), Massimo Bernardi(Vita-Salute San Raffaele University), Silvia Gregori(The San Raffaele Telethon Institute for Gene Therapy), Patrick Miqueu(European Union), Maria Teresa Lupo Stanghellini(Vita-Salute San Raffaele University), Monica Salomoni(MolMed (Italy)), Alessandro Ambrosi, Silvano Rossini, Monica E. Gianolini(The San Raffaele Telethon Institute for Gene Therapy), Jacopo Peccatori, Claudia Sartirana(The San Raffaele Telethon Institute for Gene Therapy), Barbarella Lucarelli(University of Pavia), María P. Hernández-Fuentes(King's College London), Elisabetta Zappone
Cited by 141
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
|The Journal of Experimental Medicine|1996|774
Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.
|Proceedings of the National Academy of Sciences|1991|752